Key Highlights

  • Surgery Partners (NASDAQ:SGRY) soared 47.62% on October 26, 2026 after an affiliate of Bon Secours Mercy Health agreed to buy it for USD 23.50 a share in cash, with Bain Capital rolling its roughly 39% stake.
  • Celestica (NYSE:CLS) leapt about 13% after hours with a USD 40 billion revenue outlook for 2027 and adjusted EPS of USD 3.30, while options had implied about 14.1% in published market data.
  • Lumentum (NASDAQ:LITE) jumped between 8.19% and 10% after StoneX began coverage at Buy with a USD 1,200 target, and Tesla gained about 5%, its best day since early July in published market data.
  • Cadence Design Systems (NASDAQ:CDNS) rose after hours on adjusted EPS of USD 2.11 against USD 2.05 expected and a raised 2026 outlook, although the size of the after-hours gain was not available.

Surgery Partners (NASDAQ:SGRY): Takeover Bid at USD 23.50

Surgery Partners announced on October 26, 2026 that an affiliate of Bon Secours Mercy Health will buy the company for USD 23.50 a share in cash. The enterprise value of about USD 5.7 billion combines the equity price with the company's net debt. The company release did not state a premium to the prior close or the total equity value, so those must be calculated from market prices after the merger documents are filed. Closing is expected in the first quarter of 2027. The announcement confirmed a take-private report from the previous week, and it replaces the earlier media figure of about USD 20 a share, which proved too low. A merger agreement of this kind normally includes a go-shop or no-shop clause that decides whether the board may seek better offers, and the proxy statement will describe it. In an all-cash acquisition, shareholders receive a fixed price instead of shares in the buyer, so the stock trades near the offer price less a discount for the time and risk until closing. Bain Capital's roughly 39% holding will roll into the new ownership structure, which means the largest holder is staying invested and not cashing out, a signal of continued confidence but also a sign that the other holders' vote matters less.

Celestica (NYSE:CLS): Leapt After Hours on a 2027 Outlook

Celestica (NYSE:CLS) reported third-quarter results after the close on October 26, 2026. Adjusted earnings were USD 3.30 a share, above the company's guidance. Management set a revenue outlook of USD 40 billion for 2027. The shares rose about 13% in after-hours trading. The company also lists in Toronto. The consensus figures for the quarter were not available in the information reviewed, so the size of the beat against analyst estimates cannot be stated. After-hours moves are less reliable than regular-session moves because fewer shares trade. A beat against guidance is a different test from a beat against analyst consensus, because companies often guide cautiously. The USD 40 billion outlook, however, is the headline that drew attention, since it implies very large growth from current levels. Celestica builds electronics and systems for large technology customers, and AI data centres have raised demand for servers, networking equipment and related hardware. A USD 40 billion revenue outlook for 2027 signals that management expects orders from cloud and AI customers to grow sharply, though an outlook is a target rather than a contract.

Lumentum (NASDAQ:LITE): Jumped on StoneX Coverage

StoneX initiated coverage of Lumentum (NASDAQ:LITE) at Buy on October 26, 2026 with a price target of USD 1,200. The stock rose 8.19% in the close reading, 8.89% in another and 10% in a third, so the figure is best described as a range. Coherent rose 5.83% in one reading and above 7% in another, and Applied Optoelectronics rose more than 9% in a single reading. The shares moved as part of a chip rebound in which the Philadelphia Semiconductor Index rose 2.82% to 11,083.47. A new analyst initiation is a single opinion, but it can draw attention and trading volume. The USD 1,200 target is the analyst's estimate of fair value at some future date, and the note does not guarantee a gain. AI data centres link thousands of processors, and the connections between them are increasingly optical, using lasers and transceivers to move data over light instead of copper wire. Companies that make those components benefit when customers expand clusters, because every additional server rack needs more links.

Tesla (NASDAQ:TSLA): Upgraded by Barclays

Barclays upgraded Tesla (NASDAQ:TSLA) to Overweight on October 26, 2026 and raised its price target to USD 450 from USD 370. The note cited a possible combination of Tesla and SpaceX, an idea the analyst raised and neither company has confirmed. The stock rose about 5% to 6% depending on the reading, its best session since early July, with the close reading near 5.2% and a live account at about 6%. Tesla had already reported third-quarter results the week before, so the jump was driven by the analyst call and the speculation, not by fresh company figures. Barclays' note moved the stock even though the underlying business had not changed that day. The Overweight label tells clients to hold more of the stock than its benchmark weight. A combination between two companies controlled in large part by the same executive would raise questions about valuation, governance and conflicts of interest, since each side would need independent review. For investors, the appeal is the idea of joining an electric-vehicle maker with a space and satellite business that now trades on public markets and whose shares are well below their USD 225.64 record.

Cadence Design Systems (NASDAQ:CDNS): Rose After Hours on a Raised Outlook

Cadence Design Systems (NASDAQ:CDNS) reported third-quarter results after the close on October 26, 2026. Adjusted earnings were USD 2.11 a share against a consensus of USD 2.05, and revenue was USD 1.63 billion. The company raised its 2026 outlook. The size of the after-hours gain and the new guidance ranges were not available in the information reviewed, so this article does not state them. Chip stocks had already rallied during the session, with the Philadelphia Semiconductor Index up 2.82% to 11,083.47, which means expectations were somewhat higher going into the report. A modest earnings beat is typical for software companies that guide conservatively, so the raised outlook is often the more informative number. Investors will compare the new ranges with analyst estimates once the call is available. Electronic design automation software is used to design, simulate and verify chips before they are manufactured. Customers may also delay projects if their own budgets tighten.

Where Things Stand

The answer is that the five rallies had five different drivers: a takeover bid at Surgery Partners (NASDAQ:SGRY), an outlook at Celestica, analyst coverage at Lumentum, a rating upgrade at Tesla and a raised forecast at Cadence Design Systems. Only Surgery Partners (NASDAQ:SGRY)'s gain is backed by a definitive agreement. The others rest on guidance or opinion. Closing conditions, cloud spending updates and regular-session prices on October 27, 2026 are the next tests. Further disclosure from Lumentum (NASDAQ:LITE) would clarify the picture. Official notices from Tesla (NASDAQ:TSLA) remain the best guide. Later reporting on Tesla (NASDAQ:TSLA) will add detail. Further disclosure from Tesla (NASDAQ:TSLA) would clarify the picture. Official notices from Cadence Design Systems (NASDAQ:CDNS) remain the best guide. Later reporting on Cadence Design Systems (NASDAQ:CDNS) will add detail.